FDA — authorised 22 March 1996
- Application: NDA020351
- Marketing authorisation holder: GE HEALTHCARE
- Status: supplemented
🇺🇸 Visipaque in United States
FDA authorised Visipaque on 22 March 1996
Marketing authorisations
FDA — authorised 29 August 1997
- Application: NDA020808
- Marketing authorisation holder: GE HEALTHCARE
- Status: supplemented
FDA
- Status: approved
Other Other approved in United States
Frequently asked questions
Is Visipaque approved in United States?
Yes. FDA authorised it on 22 March 1996; FDA authorised it on 29 August 1997; FDA has authorised it.
Who is the marketing authorisation holder for Visipaque in United States?
GE HEALTHCARE holds the US marketing authorisation.